The association between changes in symptoms or quality of life and overall survival in outpatients with advanced cancer
- PMID: 35542972
- DOI: 10.21037/apm-22-33
The association between changes in symptoms or quality of life and overall survival in outpatients with advanced cancer
Abstract
Background: Several prognostic tools have been developed to aid clinicians in survival prediction. However, changes in symptoms are rarely included in established prognostic systems. We aimed to investigate the influence of changes in symptoms and quality of life (QOL) on survival time in outpatients with advanced cancer.
Methods: Study subjects included a subgroup of those with longitudinal symptom and QOL data within a larger, single-site parent study. We assessed patients' symptoms and QOL at enrollment and follow-up at an approximately 3-month interval. Patients' symptoms were evaluated by the Korean version of the Edmonton Symptom Assessment System (K-ESAS). QOL was checked by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Participants were categorized into three groups by changes in symptoms or QOL. These groups were: improved (having at least a one level of improvement in the response scale), stable (no change), or worsened (at least a one level of worsening in the scale). We compared survival time in the improved plus stable vs. worsened groups, using a log-rank test.
Results: We analyzed 60 patients, with a median survival time of 346 days. In the Worsened group, depression (P<0.01) and sleep disturbance (P<0.01) by K-ESAS, and dyspnea (P<0.03) per the EORTC QLQ-C30, were statistically significantly related to shorter survival time compared to 'improved and stable' group. There was no relationship between changes in other symptoms, overall QOL, and survival.
Conclusions: Longitudinal assessment of depression, sleep disturbance and dyspnea may be useful in prognostication of patients with advanced cancer. Further studies are needed to confirm our findings with more consecutive assessments in diverse populations.
Keywords: Advanced cancer; changes of quality of life (changes of QOL); changes of symptoms; prediction; survival.
Similar articles
-
Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK + non-small cell lung cancer (ALTA-1L).Lung Cancer. 2021 May;155:68-77. doi: 10.1016/j.lungcan.2021.03.005. Epub 2021 Mar 9. Lung Cancer. 2021. PMID: 33744781 Clinical Trial.
-
Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.Oncology. 2008;74 Suppl 1:7-12. doi: 10.1159/000143212. Epub 2008 Aug 28. Oncology. 2008. PMID: 18758191
-
EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.Support Care Cancer. 2014 Jul;22(7):1941-8. doi: 10.1007/s00520-014-2173-8. Epub 2014 Mar 1. Support Care Cancer. 2014. PMID: 24577883
-
The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.Oncologist. 2020 Apr;25(4):e722-e732. doi: 10.1634/theoncologist.2019-0348. Epub 2019 Oct 31. Oncologist. 2020. PMID: 32297435 Free PMC article. Review.
-
Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.Ann Oncol. 1998;9 Suppl 5:S147-54. doi: 10.1093/annonc/9.suppl_5.s147. Ann Oncol. 1998. PMID: 9926255 Review.
Cited by
-
Relationship between psychological resilience and quality of life in cancer patients and the multiple mediating roles of stigma and self perceived burden.Sci Rep. 2025 Apr 11;15(1):12375. doi: 10.1038/s41598-025-96460-2. Sci Rep. 2025. PMID: 40210934 Free PMC article.
-
Relationship between quality of life before treatment and survival in patients with hematological malignancies: A meta-analysis.Fukushima J Med Sci. 2025 Apr 19;71(2):73-84. doi: 10.5387/fms.24-00042. Epub 2025 Feb 8. Fukushima J Med Sci. 2025. PMID: 39909447 Free PMC article.
-
Longitudinal assessment of quality of life indicators and prognosis in esophageal cancer patients with curative resection.J Thorac Dis. 2024 Sep 30;16(9):6064-6080. doi: 10.21037/jtd-24-311. Epub 2024 Sep 26. J Thorac Dis. 2024. PMID: 39444865 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical